NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

In the IG primary yesterday, two issues were priced totaling US$2.8bn, lifting weekly IG issuance to US$15.90bn and September volume to US$135.70bn, according to IFR data. The average book order for ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

BioAge Labs, a clinical-stage biotech firm focused on obesity and metabolic disease therapies, aims to raise up to $157.5 million through its initial public offering and private placement, Bloomberg ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Obesity drug developer BioAge Labs (BIOA) files for U.S. IPO to offer 7.5M shares at $17-$19 implying valution of up to $602M ...

It is joining the initial public offering (IPO) queue amid a flurry of IPO activity in the sector, with three biotechs ...

The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

(Reuters) - MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic disorders, including ...